CD11b agonists offer a novel approach for treating lupus nephritis is a research paper published in Translational research (2022). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: F31DK129006
National Cancer Institute
Grant: R01CA244938
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK084195
Michael J. Fox Foundation for Parkinson's Research
Grant: ASAP-000523
Fundação para a Ciência e a Tecnologia, I.P.
Grant: Incentivo/SAU/LA0001/2013
Incentive - LA 1 - 2013
National Institutes of Health
Grant: 5R01CA244938-04
Exploiting Integrin Signaling to Overcome Resistance to Immunotherapy
National Institutes of Health
Grant: 7R01DK084195-03
Novel Small Molecule Agonists of Integrin CD11b/CD18 as Anti-Inflammatory Agents
Aligning Science Across Parkinson’s
FWCI
2.88
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals